InvestorsHub Logo
Followers 61
Posts 7538
Boards Moderated 2
Alias Born 02/10/2010

Re: NSchai1 Beethoven post# 4505

Saturday, 04/06/2013 4:54:16 PM

Saturday, April 06, 2013 4:54:16 PM

Post# of 43787
Agreed Nschai1 - one of the side effects of moving ponderously toward approval (& methodically IMO) is that if/when the Phase III trials are completed here CVM will have the capibility to produce Multikine in sufficient quantity to satisfy short-term demand.

Also via their associates in Isreal and Taiwan CVM will have access to facilities and distribution networks overseas in short-order should all go to plan.

If (and it does remain an if - if not an extremely big gamble) the trials go as planned with success in treatment demonstrated,... the take-off should be fairly abrupt and much smoother than Dendreon experienced.

“The two most powerful warriors are patience and time.”
- Leo Nikolaevich Tolstoy

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News